Do statins cause myopathy by lowering vitamin E levels?

by Francesco Galli, Luigi Iuliano
Medical hypotheses ()


Statins and other lipid lowering drugs have been repeatedly described to decrease blood levels of minor fat soluble components such as vitamin E (as alpha-tocopherol). Clinical consequences of this secondary state of deficiency have not been described so far, but recent biochemical and molecular evidence on homeostatic and molecular responses to vitamin E deficiency in skeletal muscle cells may suggest the hypothesis presented in this paper of a role as risk factor in the development of statin-associated myopathy. This hypothesis that needs to be further investigated, could suggest the need for precautionary measures during lipid lowering therapy, which include timely diagnosis and active prevention of vitamin E deficiency.

Cite this document (BETA)

Authors on Mendeley

Readership Statistics

8 Readers on Mendeley
by Discipline
by Academic Status
38% Student (Master)
25% Student (Postgraduate)
13% Ph.D. Student
by Country
13% Portugal

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in